From Chemotherapy Re-Engineering to Biomarker-Defined Combination Treatment
Editor’s Note: From Innovation to a Partner-Ready Asset Welcome to Global Innovation Asset Insight, a MeritsIP publication examining how emerging life science programs can translate into